Company: PACB
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001299130-25-000168
Chunk: 8

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 8
---
$422 $(2,148,926)$506,594 Net loss—— — — (506,005)(506,005)Other comprehensive loss—— — (7)— (7)Issuance of common stock in conjunction with equity plans7,4358 3,420 — — 3,428 Share-based compensation expense—— 32,080 — — 32,080 Balance at September 30, 2025301,853$302 $2,690,304 $415 $(2,654,931)$36,090 

Three Months Ended September 30, 2024Common StockAdditional Paid-inCapitalAccumulatedOtherComprehensive(Loss) IncomeAccumulated DeficitTotalStockholders'Equity(In thousands)SharesAmountBalance at June 30, 2024272,491$272 $2,583,523 $(523)$(2,090,572)$492,700 Net loss—— — — (60,725)(60,725)Other comprehensive income—— — 2,076 — 2,076 Issuance of common stock in conjunction with equity plans1,3212 810 — — 812 Share-based compensation expense—— 18,259 — — 18,259 Balance at September 30, 2024273,812$274 $2,602,592 $1,553 $(2,151,297)$453,122 

Nine Months Ended September 30, 2024Common StockAdditional Paid-inCapitalAccumulatedOtherComprehensive IncomeAccumulated DeficitTotalStockholders'Equity(In thousands)SharesAmountBalance at December 31, 2023267,744$268 $2,539,892 $219 $(1,839,075)$701,304 Net loss—— — — (312,222)(312,222)Other comprehensive income—— — 1,334 — 1,334 Issuance of common stock in conjunction with equity plans6,0686 7,697 — — 7,703 Share-based compensation expense—— 55,003 — — 55,003 Balance at September 30, 2024273,812$274 $2,602,592 $1,553 $(2,151,297)$453,